Tocilizumab, an antibody against IL-6, used to reduce the cytokine storm, seems to increase anabolic muscle processes in the long-term, as demonstrated by DXA(Osteodensitometry) measurements in rheumatoid arthritis patients [30,54]. The gene discussed is IL6; the disease is rheumatoid arthritis.